EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access

eGFR Discordance and Its Association with Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation and Adoptive T-Cell Therapies

Api Chewcharat iD, Rajesh Anumolu iD, Aditya Suresh iD, Karla Sofia Yamada iD, Jessica L Ortega iD, Ansh K Mehta iD, Kiana M Zargari, Mia B Rubman, Firasat M Alikhan, Zachariah DeFilipp iD, Raad B Chowdhury iD, Caron A Jacobson und 7 weitere

Journal of the American Society of Nephrology · 2026-11 · 37 (11) · 2470-2482

DOI: 10.1681/asn.0000001119 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of the American Society of Nephrology, online erschienen am 21.04.2026. Verfasst von Api Chewcharat und 18 weiteren Autor:innen. Beteiligte Einrichtung: Division of Renal Medicine, Department of Medicine, Mass General Brigham, Boston, Massachusetts. Hauptthemen laut MEDLINE: Acute Kidney Injury, Glomerular Filtration Rate, Hematopoietic Stem Cell Transplantation, T-Lymphocytes. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, American Kidney Fund, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Key Points eGFR discordance was associated with higher risk of AKI in allogeneic hematopoietic stem cell transplantation and adoptive T-cell therapies. Among hematopoietic stem cell transplantation recipients, eGFR discordance was associated with slower time-to-platelet engraftment. Among adoptive T-cell recipients, eGFR discordance was associated with prolonged cytopenia.

Background

Discordance between eGFR on the basis of serum creatinine (eGFR cr ) versus cystatin C (eGFR cys ) is associated with adverse outcomes in patients with and without cancer. We hypothesized that eGFR discordance is associated with AKI and death after hematopoietic stem cell transplantation (HSCT) or receipt of adoptive T-cell therapies.

Methods

We conducted a multicenter study of adults receiving allogeneic HSCT and adoptive T-cell therapies who had paired serum creatinine and cystatin C values obtained in the 30 days preceding conditioning or lymphodepleting chemotherapy. The primary exposure was eGFR discordance, defined as eGFR cys ≥30% lower than eGFR cr . The primary outcome was a composite outcome of AKI (≥50% increase in serum creatinine or receipt of KRT) or death within 90 days after HSCT or adoptive T-cell infusion. Secondary outcomes included time-to-platelet engraftment in HSCT and prolonged cytopenia in adoptive T-cell recipients. We used multivariable logistic regression and cause-specific Cox regression with inverse probability weighting to adjust for confounders.

Results

Of 274 patients receiving HSCT (median age, 65 years; interquartile range, 52–71; 43% female), 86 (31%) had an eGFR discordance. Among 236 adoptive T-cell recipients (median age, 67 years; interquartile range, 60–74; 59% female), 78 (33%) had a discordance in eGFR. eGFR discordance was associated with higher odds of AKI or death in HSCT (odds ratio, 1.75; 95% confidence interval, 1.03 to 3.02) and adoptive T-cell recipients (odds ratio, 2.37; 95% confidence interval, 1.12 to 4.94). However, adjustment for eGFR cr-cys attenuated these associations in both cohorts. eGFR discordance was also associated with slower time-to-platelet engraftment in HSCT recipients and prolonged cytopenia after adoptive T-cell therapy.

Conclusions

A pretreatment eGFR discordance was associated with AKI or death in HSCT and adoptive T-cell recipients; however, this association was attenuated after adjusting for eGFR cr-cys .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Kidney InjuryGlomerular Filtration RateHematopoietic Stem Cell TransplantationT-LymphocytesAdultAgedFemaleHumansMaleMiddle AgedCreatinineTransplantation, Homologous

Stichwörter der Autor:innen

AKIAKI and critical carecreatininestem cell

Substanzen

Creatinine

Autor:innen und Institutionen

  • Division of Renal Medicine, Department of Medicine, Mass General Brigham, Boston, Massachusetts.
  • Harvard Medical School, Boston, Massachusetts.
  • UMass Chan Medical School, Worcester, Massachusetts.
  • Division of Hematologic Malignancies, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, Massachusetts.
  • Adult Survivorship Program, Dana Farber Cancer Institute, Boston, Massachusetts.

ORCID-Profile: Api Chewcharat, Rajesh Anumolu, Aditya Suresh, Karla Sofia Yamada, Jessica L Ortega, Ansh K Mehta, Zachariah DeFilipp, Raad B Chowdhury, Omar Nadeem, Robert J Soiffer, Rizwan Romee, Roman M Shapiro, Shruti Gupta

Förderung

  • NIDDK NIH HHS
  • American Kidney Fund
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Chewcharat, A., Anumolu, R., Suresh, A., Yamada, K. S., Ortega, J. L., Mehta, A. K., Zargari, K. M., Rubman, M. B., Alikhan, F. M., DeFilipp, Z., Chowdhury, R. B., Jacobson, C. A., Nadeem, O., Soiffer, R. J., Leaf, D. E., Sise, M. E., Romee, R., Shapiro, R. M., & Gupta, S. (2026). eGFR Discordance and Its Association with Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation and Adoptive T-Cell Therapies. Journal of the American Society of Nephrology, 37(11), 2470-2482. https://doi.org/10.1681/asn.0000001119

Vancouver

Chewcharat A, Anumolu R, Suresh A, Yamada KS, Ortega JL, Mehta AK, et al. eGFR Discordance and Its Association with Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation and Adoptive T-Cell Therapies. Journal of the American Society of Nephrology. 2026;37(11):2470-2482. doi:10.1681/asn.0000001119

BibTeX
@article{Chewcharat2026,
  author = {Chewcharat, Api and Anumolu, Rajesh and Suresh, Aditya and Yamada, Karla Sofia and Ortega, Jessica L and Mehta, Ansh K and Zargari, Kiana M and Rubman, Mia B and Alikhan, Firasat M and DeFilipp, Zachariah and Chowdhury, Raad B and Jacobson, Caron A and Nadeem, Omar and Soiffer, Robert J and Leaf, David E and Sise, Meghan E and Romee, Rizwan and Shapiro, Roman M and Gupta, Shruti},
  title = {eGFR Discordance and Its Association with Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation and Adoptive T-Cell Therapies},
  journal = {Journal of the American Society of Nephrology},
  year = {2026},
  volume = {37},
  number = {11},
  pages = {2470--2482},
  doi = {10.1681/asn.0000001119}
}
Kostenlos starten →